PSOPX | VISVX | PSOPX / VISVX | |
Total Expense Ratio | 0.94 | 0.19 | 495% |
Annual Report Gross Expense Ratio | 1.01 | 0.19 | 532% |
Fund Existence | 30 years | 27 years | - |
Gain YTD | -5.644 | -2.372 | 238% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.18B | 51.7B | 2% |
Annual Yield % from dividends | 0.99 | 2.21 | 45% |
Returns for 1 year | -7.00 | 2.52 | -277% |
Returns for 3 years | 0.37 | 23.69 | 2% |
Returns for 5 years | 43.92 | 95.46 | 46% |
Returns for 10 years | -1.51 | 83.12 | -2% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VWO | 47.71 | -0.12 | -0.25% |
Vanguard FTSE Emerging Markets ETF | |||
OCTW | 35.86 | -0.27 | -0.75% |
AllianzIM US Large Cap Buffer20 Oct ETF | |||
RYLD | 14.30 | -0.27 | -1.85% |
Global X Russell 2000 Covered Call ETF | |||
BLDG | 23.84 | -0.49 | -2.01% |
Cambria Global Real Estate ETF | |||
CURE | 73.62 | -5.69 | -7.17% |
Direxion Daily Healthcare Bull 3X ETF |